Cas:127-19-5 N,N-Dimethylacetamide manufacturer & supplier

Chemical Name:N,N-Dimethylacetamide

CAS.NO:127-19-5

Synonyms:Acetic Acid Dimethylamide;N,N-Dimethylacetamide;MFCD00000868;Dimethylamide acetate;DIMETHYL ACETAMIDE;N.N-Dimethylacetamide;N-N-Dimethylacetamide;N,N-dimethyl-acetamide;N-Acetyldimethylamine;Acetdimethylamide;DMAc;Acetamide, N,N-dimethyl-;Acetic acid N,N-dimethylamide;Dimethylacetone amide;EINECS 201-152-2;Acetic acid-dimethylamide;Acetamide,N,N-dimethyl;Ethanoic acid N,N-dimethylamide;DMA;Dimethylacetamide;N,N-Dimethylethanamide;N,N-Dimethyl acetamide;N,N-Dimethylacetamid

Molecular Formula:C₄H₉NO

Molecular Weight:87.120

HS Code:2924199090

Physical and Chemical Properties:

Melting point:-20 °C

Boiling point:166.1±0.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.407

PSA:20.31000

Exact Mass:87.068413

LogP:-0.75

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1279 3/PG 2

Packing Group:

Contact us for information like Acetic Acid Dimethylamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N-Dimethylacetamid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,DIMETHYL ACETAMIDE Use and application,Acetic acid-dimethylamide technical grade,usp/ep/jp grade.

Related News: Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. N,N-Dimethylacetamide manufacturer A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. N,N-Dimethylacetamide supplier Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. N,N-Dimethylacetamide vendor The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. N,N-Dimethylacetamide factory A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting.